Micheau, Olivier
TRAIL, Fas Ligand, TNF and TLR3 in Cancer
1. Resistance to TRAIL Pathway-Targeted Therapeutics in Cancer
Jessica Wagner, Christina Leah Kline, Wafik El-Deiry
2. TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer
Lubna Danish, Daniela Stöhr, Peter Scheurich, Nadine Pollak
3. IAPs and Resistance to Death Receptors in Cancer
Laurence Dubrez, Simone Fulda
4. Bcl-2 Proteins and TRAIL Resistance in Melanoma
Jürgen Eberle
5. Regulation of Caspase-Mediated Apoptosis by the Tumor Suppressor Par-4
James Sledziona, Vivek M. Rangnekar
6. Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy
Andrea Mohr, Ralf Zwacka
7. Atypical Immune Functions of CD95/CD95L
Amanda Poissonnier, Patrick Legembre
8. TLR3 Is a Death Receptor Target in Cancer Therapy
Yann Estornes, Toufic Renno, Serge Lebecque
9. Fas/CD95, Lipid Rafts, and Cancer
Faustino Mollinedo, Consuelo Gajate
10. Role of Sphingolipids in Death Receptor Signalling
Fatima Bilal, Michaël Pérès, Nathalie Andrieu-Abadie, Thierry Levade, Bassam Badran, Ahmad Daher, Bruno Ségui
11. Posttranslational Modifications and Death Receptor Signalling
Olivier Micheau
12. System Modeling of Receptor-Induced Apoptosis
François Bertaux, Dirk Drasdo, Grégory Batt
Avainsanat: Biomedicine, Cancer Research
- Toimittaja
- Micheau, Olivier
- Julkaisija
- Springer
- Julkaisuvuosi
- 2017
- Kieli
- en
- Painos
- 1
- Sarja
- Resistance to Targeted Anti-Cancer Therapeutics
- Sivumäärä
- 13 sivua
- Kategoria
- Terveys, kauneus, muoti
- Tiedostomuoto
- E-kirja
- eISBN (PDF)
- 9783319568058
- Painetun ISBN
- 978-3-319-56804-1